Smoking in inflammatory bowel diseases: good, bad or ugly?
Smoking is an important environmental factor in inflammatory bowel disease (IBD), having different effects in ulcerative colitis (UC) and Crohn's disease (CD). A recent meta-analysis partially confirmed previous findings that smoking was found to be protective against ulcerative colitis and, after onset of the disease, might improve its course, decreasing the need for colectomy. However, smoking increases the risk of developing CD and worsens its course, increasing the need for steroids, immunosuppressants and re-operations. Smoking cessation aggravates ulcerative colitis and improves CD. Data are however, largely conflictive as well as the potential mechanisms involved in this dual relationship are still unknown. In this review article, the authors review the role of smoking in inflammatory bowel diseases.
Lakatos
Peter Laszlo
PL
Szamosi
Tamas
T
Lakatos
Laszlo
L
D003093:Colitis, Ulcerative / Q000503:physiopathology / Q000517:prevention & control; D003424:Crohn Disease / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000209:etiology / Q000503:physiopathology* / Q000517:prevention & control; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects / Q000503:physiopathology*; D016540:Smoking Cessation